Samatasvir
CAS No. 1312547-19-5
Samatasvir( ATOLIHZIXHZSBA-BTSKBWHGSA-N | IDX719 )
Catalog No. M28765 CAS No. 1312547-19-5
Samatasvir is a pan-genotypic inhibitor of the HCV non-structural protein 5A.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 198 | In Stock |
|
| 5MG | 112 | In Stock |
|
| 10MG | 186 | In Stock |
|
| 25MG | 376 | In Stock |
|
| 50MG | 619 | In Stock |
|
| 100MG | 986 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSamatasvir
-
NoteResearch use only, not for human use.
-
Brief DescriptionSamatasvir is a pan-genotypic inhibitor of the HCV non-structural protein 5A.
-
DescriptionSamatasvir is a pan-genotypic inhibitor of the HCV non-structural protein 5A.
-
In VitroSamatasvir (IDX719) retains full activity in the presence of HIV and hepatitis B virus (HBV) antivirals and is not cross-resistant with HCV protease, nucleotide, and nonnucleoside polymerase inhibitor classes.
-
In Vivo——
-
SynonymsATOLIHZIXHZSBA-BTSKBWHGSA-N | IDX719
-
PathwayMicrobiology/Virology
-
TargetHCV
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1312547-19-5
-
Formula Weight885.07
-
Molecular FormulaC47H48N8O6S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (56.49 mM)
-
SMILESCOC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c1nc2ccc(cc2[nH]1)-c1csc2c(csc12)-c1ccc(cc1)-c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@H](NC(=O)OC)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Casper DM, et al. Toward the development of a structurally novel class of chiral auxiliaries: diastereoselective aldol reactions of a (1R,2S)-ephedrine-based 3,4,5,6-tetrahydro-2H-1,3,4-oxadiazin-2-one. Org Lett. 2002 Oct 17;4(21):3739-42.
molnova catalog
related products
-
Chlorcyclizine
CHLORCYCLIZINE is a histamine H1 antagonist and a potent hepatitis C virus (HCV) entry inhibitor.
-
Deleobuvir
Deleobuvir (BI-207127, BI207127) is a potent, selective HCV NS5B polymerase inhibitor with IC50 of 50 nM against GT-1 HCV polymerase activity.
-
HCV-IN-31
HCV-IN-31 is a HCV inhibitor with an EC50/EC95 of 15.7 μM.
Cart
sales@molnova.com